Autoantibodies recognizing SRP54, a myositis-associated autoantigen, increased by over 4-fold between the first and second time points in individual AA19 who also carried anti–PDC-E2 and anti–TPO CTD-AAbs at baseline. This evidence concerns the gene SRP54 and myositis disease.